The role of dobutamine stress cardiovascular magnetic resonance in the clinical management of patients with suspected and known coronary artery disease

Table 4 Hemodynamic data

	All patients	DCMR-pos	DCMR-neg
	n = 1532	n = 609	n = 923	p^†
Hemodynamic data
Dobutamine dose (μg/kg/min)	35 ± 8	35 ± 8	35 ± 8	0.5
Atropine dose (mg)	0.25 ± 0.35	0.26 ± 0.36	0.24 ± 0.35	0.27
Resting HR, beats/minute	73 ± 13	72 ± 14	73 ± 13	0.008
Peak HR, beats/minute	139 ± 10	138 ± 11	140 ± 10	<0.001
Target HR achieved, %	94	91	97	<0.001
Resting SBP, mmHg	132 ± 22	133 ± 23	132 ± 22	0.68
Peak SBP, mmHg	141 ± 30	141 ± 32	141 ± 29	0.83
Resting Rate Pressure Product	9691 ± 2748	9607 ± 2829	9747 ± 2695	0.12
Peak Rate Pressure Product	18759 ± 4275	18893 ± 4351	18667 ± 4236	0.31

ISSN: 1532-429X